[{"id":"3b54b1fd-0ac2-4d1f-9bb0-2c08867b5dce","acronym":"abl LMC","url":"https://clinicaltrials.gov/study/NCT01650467","created_at":"2021-01-18T07:06:40.375Z","updated_at":"2024-07-02T16:37:26.075Z","phase":"","brief_title":"Imatinib Response in Patients With Chronic Myeloid Leukemia (CML) in Function of Abl Polymorphisms","source_id_and_acronym":"NCT01650467 - abl LMC","lead_sponsor":"Centre Hospitalier Universitaire de Nīmes","biomarkers":" ABL1 • BCR • ITK","pipe":"","alterations":" ","tags":["ABL1 • BCR • ITK"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e imatinib"],"overall_status":"Withdrawn","enrollment":"","initiation":"Initiation: 12/01/2014","start_date":" 12/01/2014","primary_txt":" Primary completion: 06/01/2017","primary_completion_date":" 06/01/2017","study_txt":" Completion: 06/01/2017","study_completion_date":" 06/01/2017","last_update_posted":"2017-02-01"},{"id":"d993d790-f435-45b7-9e89-b6963a662e11","acronym":"","url":"https://clinicaltrials.gov/study/NCT01490801","created_at":"2021-01-18T06:14:13.177Z","updated_at":"2024-07-02T16:37:32.099Z","phase":"","brief_title":"Biomarkers in Blood and Tissue Samples From Patients With Epstein-Barr Virus-Positive Hodgkin Lymphoma","source_id_and_acronym":"NCT01490801","lead_sponsor":"Children's Oncology Group","biomarkers":" ITK","pipe":"","alterations":" ","tags":["ITK"],"overall_status":"Completed","enrollment":" Enrollment 50","initiation":"Initiation: 12/01/2011","start_date":" 12/01/2011","primary_txt":" Primary completion: 05/01/2016","primary_completion_date":" 05/01/2016","study_txt":" Completion: 05/01/2016","study_completion_date":" 05/01/2016","last_update_posted":"2016-05-17"}]